Year: 2025
-
Federal Circuit Reverses Invalidity Finding for Novartis’ Entresto Patent
On January 10, 2025, the Federal Circuit issued a significant decision in In re Entresto (Sacubitril/Valsartan) Patent Litigation, reversing a district court ruling that had found claims of Novartis’ U.S. Patent 8,101,659 (“the ’659 patent”) invalid for lack of written description. The appellate court affirmed the district court’s rulings that the patent was not invalid…
-
Court Upholds Limited Damages in Bitmanagement Software GmbH v. United States: Key Takeaways on Copyright Infringement and Licensing
On January 7, 2025, the United States Court of Appeals for the Federal Circuit issued its decision in Bitmanagement Software GmbH v. United States, affirming a damages award of $154,400 for copyright infringement by the U.S. Navy. The case centered around the Navy’s unauthorized copying and use of Bitmanagement’s 3D rendering software, BS Contact Geo,…
-
Federal Circuit Ruling on Oman Fasteners: A Critical Look at Antidumping Duties and Administrative Review Standards
On January 7, 2025, the U.S. Court of Appeals for the Federal Circuit issued an important ruling in Oman Fasteners, LLC v. United States, a case that highlights key issues in international trade law, including antidumping duties, administrative review procedures, and the application of adverse inferences under 19 U.S.C. § 1677e. The decision sheds light…
-
Functionality and Trademark Law: The Federal Circuit’s Decision in CeramTec GmbH v. CoorsTek Bioceramics LLC
In a significant ruling on the intersection of patent and trademark law, the U.S. Court of Appeals for the Federal Circuit recently upheld the cancellation of CeramTec GmbH’s trademarks for the pink color of ceramic hip components. The court affirmed the decision of the Trademark Trial and Appeal Board (TTAB), finding that the color pink…
-
Federal Circuit Overturns PTAB Decision in Honeywell v. 3G Licensing: A Victory for Obviousness Challenges
On January 2, 2025, the Federal Circuit issued a significant ruling in Honeywell International Inc. v. 3G Licensing, S.A., reversing the Patent Trial and Appeal Board’s (PTAB) decision that upheld the validity of U.S. Patent No. 7,319,718. This ruling underscores the court’s approach to obviousness under 35 U.S.C. § 103 and highlights critical considerations in…